Initial oral immunization experiments showed that feeding small amounts (2–20 μg) of CTB-INS could effectively suppress β-cell destruction and clinical diabetes in pre-diabetic NOD mice [123,124,141]. This evidence concerns the gene INS and diabetes mellitus.